A Study of Gimatecan (ST1481) in Small Cell Lung Cancer

Clinical trial NCT04501029 · UNKNOWN

Trial details

NCT number: NCT04501029
Sponsor: Lee's Pharmaceutical Limited
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2020-10-01
Primary completion: 2022-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.